Ausgabe 3/2017
Inhalt (34 Artikel)
Whither surgical quality assurance of breast cancer surgery (surgical margins and local recurrence) after paterson
N. J. Bundred, J. Thomas, J. M. J. Dixon
Preoperative paravertebral blocks for the management of acute pain following mastectomy: a cost-effectiveness analysis
Anaeze C. Offodile II, Clifford C. Sheckter, Austin Tucker, Anna Watzker, Kevin Ottino, Martin Zammert, William V. Padula
Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer
Xavier Ghislain Léon Victor Pouwels, Bram L. T. Ramaekers, Manuela A. Joore
Predictive factors on outcomes in metaplastic breast cancer
C. Marc Leyrer, Camille A. Berriochoa, Shree Agrawal, Alana Donaldson, Benjamin C. Calhoun, Chirag Shah, Robyn Stewart, Halle C. F. Moore, Rahul D. Tendulkar
A step-by-step oncoplastic breast conservation surgical atlas of reproducible dissection techniques and anatomically ideal incision placement
Sunny D. Mitchell
Pro-apoptotic effect of Δ2-TGZ in “claudin-1-low” triple-negative breast cancer cells: involvement of claudin-1
Marine Geoffroy, Alexandra Kleinclauss, Stéphanie Grandemange, Sébastien Hupont, Michel Boisbrun, Stéphane Flament, Isabelle Grillier-Vuissoz, Sandra Kuntz
Erratum to: Pro-apoptotic effect of Δ2-TGZ in “claudin-1-low” triple-negative breast cancer cells: involvement of claudin-1
Marine Geoffroy, Alexandra Kleinclauss, Stéphanie Grandemange, Sébastien Hupont, Michel Boisbrun, Stéphane Flament, Isabelle Grillier-Vuissoz, Sandra Kuntz
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
Heba Alshaker, Qi Wang, Shyam Srivats, Yimin Chao, Colin Cooper, Dmitri Pchejetski
Does biomarker information impact breast cancer patients’ preferences and physician recommendation for adjuvant chemotherapy?
Ann H. Partridge, Karen Sepucha, Anne O’Neill, Kathy D. Miller, Emily Baker, Chau T. Dang, Donald W. Northfelt, George W. Sledge, Bryan P. Schneider
Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
Nicole C. Verheuvel, Adri C. Voogd, Vivianne C. G. Tjan-Heijnen, S. Siesling, Rudi M. H. Roumen
Mammographic breast density decreases after bariatric surgery
Austin D. Williams, Alycia So, Marie Synnestvedt, Colleen M. Tewksbury, Despina Kontos, Meng-Kang Hsiehm, Lauren Pantalone, Emily F. Conant, Mitchell Schnall, Kristoffel Dumon, Noel Williams, Julia Tchou
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
Ulrike Nitz, Oleg Gluz, Matthias Christgen, Ronald E. Kates, Michael Clemens, Wolfram Malter, Benno Nuding, Bahriye Aktas, Sherko Kuemmel, Toralf Reimer, Andrea Stefek, Fatemeh Lorenz-Salehi, Petra Krabisch, Marianne Just, Doris Augustin, Cornelia Liedtke, Calvin Chao, Steven Shak, Rachel Wuerstlein, Hans H. Kreipe, Nadia Harbeck
A pilot study of cabergoline for the treatment of metastatic breast cancer
Ricardo Costa, C. A. Santa-Maria, D. M. Scholtens, S. Jain, L. Flaum, W. J. Gradishar, C. V. Clevenger, V. G. Kaklamani
Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer
B. E. P. J. Vriens, I. J. H. Vriens, M. J. B. Aarts, S. M. van Gastel, F. W. P. J. van den Berkmortel, T. J. Smilde, L. J. C. van Warmerdam, D. J. van Spronsen, P. G. M. Peer, M. de Boer, V. C. G. Tjan-Heijnen
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer
Hope S. Rugo, Olivier Trédan, Jungsil Ro, Serafin M. Morales, Mario Campone, Antonino Musolino, Noémia Afonso, Marta Ferreira, Kyong Hwa Park, Javier Cortes, Antoinette R. Tan, Joanne L. Blum, Lamar Eaton, Christine K. Gause, Zhen Wang, Ellie Im, David J. Mauro, Mary Beth Jones, Andrew Denker, José Baselga
Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2− pN0 early breast cancers
Marie Viala, Marie Alexandre, Simon Thezenas, Pierre-Jean Lamy, Aurélie Maran-Gonzalez, Marian Gutowski, Pierre-Emmanuel Colombo, Gilles Romieu, William Jacot, Severine Guiu
Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease
Rhonda Arthur, Yihong Wang, Kenny Ye, Andrew G. Glass, Mindy Ginsberg, Olivier Loudig, Thomas Rohan
The effect of 14-3-3ζ expression on tamoxifen resistance and breast cancer recurrence: a Danish population-based study
Jake E. Thistle, Ylva Hellberg, Kristina Mortensen, Stephen Hamilton–Dutoit, Anders Kjærsgaard, Deirdre Cronin–Fenton, Henrik Toft Sørensen, Timothy L. Lash
Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
Karin Elebro, Pär-Ola Bendahl, Helena Jernström, Signe Borgquist
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients
Daniel L. Hertz, Kelly A. Speth, Kelley M. Kidwell, Christina L. Gersch, Zeruesenay Desta, Anna Maria Storniolo, Vered Stearns, Todd C. Skaar, Daniel F. Hayes, N. Lynn Henry, James M. Rae
Increasing utilization of regional nodal irradiation in elderly node-positive women and declining emphasis on demographic factors
Jason K. Molitoris, Tejan Diwanji, James W. Snider, Emily C. Bellavance, Susan B. Kesmodel, Paula Rosenblatt, Katherine Tkaczuk, Soren M. Bentzen, Randi J. Cohen, Elizabeth M. Nichols, Sally B. Cheston, Steven J. Feigenberg
Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance)
Shirley M. Bluethmann, Catherine M. Alfano, Jonathan D. Clapp, George Luta, Brent J. Small, Arti Hurria, Harvey J. Cohen, Steven Sugarman, Hyman B. Muss, Claudine Isaacs, Jeanne S. Mandelblatt
Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia
Xiaohong R. Yang, Beena C. R. Devi, Hyuna Sung, Jennifer Guida, Eliseos J. Mucaki, Yanzi Xiao, Ana Best, Lisa Garland, Yi Xie, Nan Hu, Maria Rodriguez-Herrera, Chaoyu Wang, Kristine Jones, Wen Luo, Belynda Hicks, Tieng Swee Tang, Karobi Moitra, Peter K. Rogan, Michael Dean
The effects of physical activity and fatigue on cognitive performance in breast cancer survivors
Diane K. Ehlers, Susan Aguiñaga, Josh Cosman, Joan Severson, Arthur F. Kramer, Edward McAuley
Patterns and predictors of first and subsequent recurrence in women with early breast cancer
Y. M. Geurts, A. Witteveen, R. Bretveld, P. M. Poortmans, G. S. Sonke, L. J. A. Strobbe, S. Siesling
Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project
Hans-Jürgen Hurtz, Hans Tesch, Thomas Göhler, Ulrich Hutzschenreuter, Johanna Harde, Lisa Kruggel, Martina Jänicke, Norbert Marschner
Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer
Zhaomei Mu, Chun Wang, Zhong Ye, Giovanna Rossi, Carl Sun, Ling Li, Zhu Zhu, Hushan Yang, Massimo Cristofanilli
Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors
Carol A. Parise, Vincent Caggiano
Oncologists’ influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?
Steven J. Katz, Sarah T. Hawley, Irina Bondarenko, Reshma Jagsi, Kevin C. Ward, Timothy P. Hofer, Allison W. Kurian
Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast
Scott Kizy, Jing Li Huang, Schelomo Marmor, Todd M. Tuttle, Jane Yuet Ching Hui
Detection of BRCA1 gross rearrangements by droplet digital PCR
Elena V. Preobrazhenskaya, Ilya V. Bizin, Ekatherina Sh. Kuligina, Alla Yu. Shleykina, Evgeny N. Suspitsin, Olga A. Zaytseva, Elena I. Anisimova, Sergey A. Laptiev, Tatiana V. Gorodnova, Alexey M. Belyaev, Evgeny N. Imyanitov, Anna P. Sokolenko
From clinical trials to clinical practice: outcome of NSABP-B27 neoadjuvant chemotherapy regimen for high-risk early-stage breast cancer
Hikmat Abdel-Razeq, Lina Marei, Salwa S. Saadeh, Hazem Abdulelah, Mahmoud Abu-Nasser, Mourad Salam, Walid Daana, Basel Al-Haj Ali, Ayat Taqash
In response to “outcomes of patients with inflammatory breast cancer treated by breast conserving surgery”: the argument against breast conservation and sentinel lymph node biopsy in IBC
Kelly J. Rosso, Naoto T. Ueno, Wendy A. Woodward, Anthony Lucci